Panacea Journal of Medical Sciences

---

A prospective study on limberg flap procedure for pilonidal sinus

Full Text PDF Share on Facebook Share on Twitter

---

Original Article

Author Details : Ashok Kumar Nayak, Sanjay Kumar Mahapatra, Akhil Unnikrishnan, Samarendra Satpathy*

Volume : 11, Issue : 2, Year : 2021

Article Page : 241-244

https://10.18231/j.pjms.2021.050

Suggest article by email

---

Abstract

Background: Pilonidal sinus is a blind ending track containing hair follicles within it and is primarily a disease involving sacrococcygeal region. The exact etiology of this disease process is unknown and is still controversial. There are various treatment methods for pilonidal sinus and the preferred method is Limberg flap reconstruction surgery due to its less complications and less recurrence.
Materials and Methods: Our study was a prospective study including 28 patients who were admitted for pilonidal sinus and operated by Limberg flap reconstruction surgery at Veer Surendra Sai Institute of Medical Sciences And Research from January 2018 to June 2020.
Results: Our study included 28 patients, and the female to male ratio is 1:13. Duration of symptoms had a range from 1-4 months and the mean age of the study population was 28.5 year. Patients underwent Limberg flap reconstruction surgery and 89.28% followed a normal course after surgery , 7.14% developed seroma and 3.57% developed surgical site infection in their post-operative period.
Conclusions: Limberg flap reconstruction surgery is the most preferred method of treatment for pilonidal sinus because of its low infection and recurrence rates, better aesthetic results after surgery and short duration of hospital stay.
 
Keywords: Pilonidal sinus, Limberg flap, Sacrococcygeal.

How to cite : Nayak A K, Mahapatra S K, Unnikrishnan A, Satpathy S, A prospective study on limberg flap procedure for pilonidal sinus. Panacea J Med Sci 2021;11(2):241-244

Copyright © 2021 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)